Yongan Pharmaceutical announced that Hong Rengui, Dong Shihao, Fang Xiquan, Wang Zhihua, and Xiong Shengjie will reduce their holdings of 33,700 shares, 271,500 shares, 52,800 shares, 66,200 shares, and 28,700 shares respectively through centralized bidding, for a total of 452,900 shares, accounting for 0.1537% of the company's total share capital. The holdings reduction plan will be implemented within 3 months after 15 trading days from the date of disclosure of the announcement.

Yongan Pharmaceutical announced that Hong Rengui, Dong Shihao, Fang Xiquan, Wang Zhihua, and Xiong Shengjie will reduce their holdings of 33,700 shares, 271,500 shares, 52,800 shares, 66,200 shares, and 28,700 shares respectively through centralized bidding, for a total of 452,900 shares, accounting for 0.1537% of the company's total share capital. The holdings reduction plan will be implemented within 3 months after 15 trading days from the date of disclosure of the announcement.